A special risk group for hepatitis E infection: the first record of North Cyprus

• Autorzy: Suer K. , Guvenir M. , Aykac A.
• Języki publikacji: EN

Abstrakty

EN

Hepatitis E virus (HEV) is transmitted by a fecal oral route from animals to humans following exposure to the body fluids of infected animals. We investigated the seroprevalence of anti-hepatitis E (anti-HEV) antibodies by monitoring IgG and IgM virus antibodies amongst employees in the animal industry in North Cyprus through a cross-sectional study. Samples were taken from individuals without occupational exposure to animals and from those who worked with animals (doing animal husbandry, veterinary work or butchery). Enzymelinked immunoassays were used to detect anti-HEV IgG and IgM in the blood samples. The prevalence of anti-HEV IgG antibodies was 3.0% (12/400), while the prevalence of anti-HEV IgM antibodies was 0.25% (1/400). The prevalence of anti-HEV IgG amongst the samples received from females was approximately 2.5-fold higher than samples received from males (2.4%). Anti-HEV IgG was detected amongst 7% of animal husbandry workers and amongst 2% of veterinarians and butchers. The current findings represent the first records of HEV surveillance in Cyprus. We investigated the seroprevalence of anti-HEV by monitoring IgG and IgM virus antibodies amongst employees.

Słowa kluczowe

EN

North Cyprus; Cyprus; risk group; hepatitis E virus; seroprevalence; zoonosis; human infection; animal; epidemiology

• Wydawca: -
• Czasopismo: Polish Journal of Microbiology
• Rocznik: 2018
• Tom: 67
• Numer: 4
• Opis fizyczny: p.525-528,ref.

Twórcy

autor

Suer K.

• Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Near East University, Nicosia, Cyprus

autor

Guvenir M.

• Vocational School of Health Services, Near East University, Nicosia, Cyprus

autor

Aykac A.

• Department of Biophysics, Faculty of Medicine, Near East University, Nicosia, Cyprus

Bibliografia

• Altındiş M. 2000. Afyon Sultandağı İlçesi Çocuklarında Hepatit A ve Hepatit E Enfeksiyon Prevelansı. Turk Hij Deney Biyol Derg. 57(3):147–152.
• Aydin H, Uyanik MH, Karamese M, Timurkan MO. 2016. Seroprevalence of hepatitis E virus in animal workers in non-porcine consumption region of Turkey. Future Virol. 11(10): 691–697.
• Ceylan A, Ertem M, Ilcin E, Ozekinci T. 2003. A special risk group for hepatitis E infection: Turkish agricultural workers who use untreated waste water for irrigation. Epidemiol Infect. 131(1):753–756.
• Eker A, Tansel O, Kunduracilar H, Tokuç B, Yuluğkural Z, Yüksel P. 2009. Hepatitis E virus epidemiology in adult population in Edirne province, Turkey. (in Turkish). Mikrobiyol Bul. 43(2):251–258.
• El-Tras WF, Tayel AA, El-Kady NN. 2013. Seroprevalence of hepatitis E virus in humans and geographically matched food animals in Egypt. Zoonoses Public Health. 60(3):244–251.
• Hesamizadeh K, Sharafi H, Keyvani H, Alavian SM, Najafi-Tireh Shabankareh A, Sharifi Olyaie R, Keshvari M. 2016. Hepatitis A virus and Hepatitis E virus seroprevalence among blood donors in Tehran, Iran. Hepat Mon. 16(1):e32215.
• Holt HR, Inthavong P, Khamlome B, Blaszak K, Keokamphe, Somoulay V, Phongmany A, Durr P.A, Graham K, Allen J, et al. 2016. Endemicity of zoonotic diseases in pigs and humans in lowland and upland Lao PDR: Identification of socio-cultural risk factors. PLoS Neql Trop Dis. 10(4):e0003913.
• Lapa D, Capobianchi M, Garbuglia A. 2015. Epidemiology of Hepatitis E Virus in European countries. Int J Mol Sci. 16(10): 25711–25743.
• Lapinski TW, Jaroszewicz J. 2016. Hepatitis E virus infection – a new threat for Europe. Przeql Epidemiol. 70(1):11–14.
• Leblebicioğlu H, Ozaras R. 2018. Hepatitis E virus infection in Turkey: a systematic review. Ann Clin Microbiol Antimicrob. 17(1):17.
• Mauceri C, Grazia Clemente M, Castiglia P, Antonucci R, Schwarz KB. 2018. Hepatitis E in Italy: A silent presence. J Infect Public Health. 11(1):1–8.
• Melgaco JG, Gardinali NR, Mello V, Leal M, Ximenez L, Pinto MA. 2018. Hepatitis E: Update on Prevention and Control. BioMed Res. Int. 2018:Article ID 5769201.
• Mohebbi SR, Rostami Nejad M, Tahaei SME, Pourhoseingholi MA, Habibi M, Azimzadeh P, Naghoosi H, Karayiannis P, Zali MR. 2012. Seroepidemiology of hepatitis A and E virus infections in Tehran, Iran: a population based study. Trans R Soc Trop Med Hyg. 106(9):528–531.
• Niederhauser C, Widmer N, Hotz M, Tinguely C, Fontana S, Allemann G, Borri M, Infanti L, Sarraj A, Sigle J, et al. 2018. Current hepatitis E virus seroprevalence in Swiss blood donors and apparent decline from 1997 to 2016. Euro Surveill. 23(35):pii1700616.
• Taherkhani R, Farshadpour F. 2016. Epidemiology of hepatitis E virus in Iran. World J Gastroenterol. 22(22):5143–5153.
• WHO. 2010. The Global Prevalence of Hepatitis E Virus Infection and Susceptibility: A Systematic Review. Geneva (Switzerland): World Health Organization.
• Wu X, Chen P, Lin H, Hao X, Liang Z. 2016. Hepatitis E virus: current epidemiology and vaccine. Hum Vaccin Immunother. 12(10): 2603–2610.

Identyfikatory

DOI

10.21307/pjm-2018-062